VIA
NUVB icon

Virtus Investment Advisers’s Nuvation Bio NUVB Stock Holding History

Virtus Investment Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$430K Buy
100,151
+19,083
+24% +$106K 0.12% 237
2025
Q4 		$726K Buy
81,068
+18,202
+29% +$113K 0.2% 156
2025
Q3 		$233K Buy
62,866
+10,914
+21% +$29.7K 0.07% 246
2025
Q2 		$101K Sell
51,952
-10,469
-17% -$21.8K 0.03% 328
2025
Q1 		$110K Buy
+62,421
New +$142K 0.03% 407

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtus Investment Advisers's NUVB Position: Q1 2026 in Review

Virtus Investment Advisers increased its Nuvation Bio (NUVB) stake by 24% in Q1 2026, buying an estimated $106K and bringing the position to 100,151 shares worth $430K. The position accounts for 0.12% of the portfolio, ranked #237.

Virtus Investment Advisers first reported a position in NUVB in Q1 2025 and has held it in 5 quarters since. The position peaked at $726K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Virtus Investment Advisers held 100,151 shares of Nuvation Bio worth $430K as of Q1 2026.
  • Virtus Investment Advisers bought 19,083 Nuvation Bio shares in Q1 2026, an estimated $106K.
  • Nuvation Bio made up 0.12% of Virtus Investment Advisers's portfolio in Q1 2026, its #237 holding.
  • Virtus Investment Advisers first reported a position in Nuvation Bio in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's Nuvation Bio position peaked at $726K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.